NCT04115930

Brief Summary

The main purpose of the study is to assess the fatigue, cognition, quality of life and disability correlation to MS-patients daily physical activity.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
61

participants targeted

Target at P25-P50 for all trials

Timeline
Completed

Started May 2018

Geographic Reach
1 country

4 active sites

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 16, 2018

Completed
11 months until next milestone

First Submitted

Initial submission to the registry

April 4, 2019

Completed
2 months until next milestone

Primary Completion

Last participant's last visit for primary outcome

June 13, 2019

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

June 13, 2019

Completed
4 months until next milestone

First Posted

Study publicly available on registry

October 4, 2019

Completed
Last Updated

October 4, 2019

Status Verified

October 1, 2019

Enrollment Period

1.1 years

First QC Date

April 4, 2019

Last Update Submit

October 3, 2019

Conditions

Outcome Measures

Primary Outcomes (15)

  • Correlation between daily physical activity and quality of life to disability.

    Daily physical activity will be measured 7 days assessed by ActiGraphTM wGT3X-BT. Person keep this on his/her wake-up time whole 7 days excluding time when she/he is in water like in shower or swimming. Quality of life will be assessed by questionnaires 15-D and RAND-36 and disability will be assessed by EDSS (Expanded Disability Status Scale) and also with MSFC (Multiple Sclerosis Functional Composite) measurement.

    Baseline (one measurement)

  • Correlation between fatigue and cognition to daily physical activity and disability.

    Fatigue will be assessed with two different questionnaires FSS (fatigue severity scale) and MFIS (Modified Fatigue Impact Scale). Cognition will be assessed SDMT (Symbol Digital Modality Test) and PASAT-test. Daily physical activity will be measured 7 days with measure ActiGraphTM wGT3X-BT. Person keep this on his/her wake-up time whole 7 days excluding time when she/he is in water like in shower or swimming. Disability will be assessed EDSS (Expanded Disability Status Scale) and also with MSFC (Multiple Sclerosis Functional Composite) measurement.

    Baseline (one measurement)

  • Correlation between fatigue, cognition, quality of life and daily physical activity.

    Fatigue will be assessed with two different questionnaires FSS (fatigue severity scale) and MFIS (Modified Fatigue Impact Scale). Cognition will be assessed SDMT (Symbol Digital Modality Test) and PASAT-test. Quality of life will be assessed questionnaires 15-D and RAND-36. Daily physical activity will be measured 7 days with measure ActiGraphTM wGT3X-BT. Person keep this on his/her wake-up time whole 7 days excluding time when she/he is in water like in shower or swimming.

    Baseline (one measurement)

  • Disability level EDSS

    Disability will be assessed EDSS (Expanded Disability Status Scale). Scale range is between 0 to 10. (0 level is normal and 10 means death)

    Baseline (one measurement)

  • Disability level MSFC

    Disability will be assessed MSFC (Multiple Sclerosis Functional Composite) measurement. Test include three different kind of test The Timed 25-Foot Walk Test, The 9-HPT (9-hole peg test) and The Paced Auditory Serial Addition Test "PASAT"). The MSFC is based on the concept that scores for these three dimensions-arm, leg, and cognitive function are combined to create a single score (the MSFC) that can be used to detect change over time in a group of multiple sclerosis patients. This is done by creating Z-scores for each component of the MSFC and averaging them to create an overall composite score known as the MSFC score. ex. MSFC Score = {Zarm, average + Zleg, average + Zcognitive} / 3.0 Where Zxxx =Z-score

    Baseline (one measurement)

  • 9-Hole Peg Test

    The 9-HPT (9-hole peg test). The 9-HPT is a quantitative measure of upper extremity (arm and hand) function. Both the dominant and non-dominant hands are tested twice (two consecutive trials of the dominant hand, followed immediately by two consecutive trials of the non-dominant hand). Record only the times for the two successfully completed trials for each hand. (time/within 0.1 seconds,lower time is better.)

    Baseline (one measurement)

  • The Timed 25-Foot Walk test

    The Timed 25-Foot Walk test is a quantitative measure of lower extremity function. The patient is directed to one end of a clearly marked 25-foot course and is instructed to walk 25 feet as quickly as possible. Record the subject's walk time to within 0.1 second, lower time is better)

    Baseline (one measurement)

  • Daily physical activity

    Daily physical activity will be measured 7 days with measure ActiGraphTM wGT3X-BT. Person keep this on his/her wake-up time whole 7 days excluding time when she/he is in water like in shower or swimming.

    7 days

  • Quality of life 15-D

    Quality of life level will be assessed questionnaire 15-D. 15 question (evaluation 5 class in every question= 1 to 5 points) Count together and higher number is worse.

    Baseline (one measurement)

  • Quality of life RAND-36

    Quality of life level will be assessed questionnaire RAND-36.(include 36 question in 8 different kind of section). Higher number is worse.

    Baseline (one measurement)

  • Cognition level SDMT

    Cognition will be assessed with SDMT (Symbol Digital Modality Test). Higher number is better.

    Baseline (one measurement)

  • Cognition level PASAT

    Cognition will be assessed with PASAT-test.(Paced Auditory Serial Addition Test). The test score is the number of correct sums given (out of 60 possible) in each trial. Higher number is better.

    Baseline (one measurement)

  • Fatigue level FSS

    Fatigue will be assessed with questionnaire FSS (fatigue severity scale). FSS questionaire containing nine statements that attempt to explore severity of fatigue symptoms. The subject is asked to read each statement and circle a number from 1 to 7. The scoring is done by calculating the average response to the questions (adding up all the answers and dividing by nine). Higher number is worse.

    Baseline (one measurement)

  • Fatigue level MFIS

    Fatigue will be assessed with questionnaire MFIS (Modified Fatigue Impact Scale). 21 questions. (scale 0 to 4 in every questions/ range 0 to 84 in whole questionnaire). Higher number is worse.

    Baseline (one measurement)

  • General condition (endurance)

    General condition (endurance) assessed by 6-minutes walking test distance in meters.

    Baseline (one measurement)

Secondary Outcomes (6)

  • Body Composition Weight

    Baseline (one measurement)

  • Body Composition Height

    Baseline (one measurement)

  • Body Composition Weist

    Baseline (one measurement)

  • Body Composition BMI

    Baseline (one measurement)

  • Equilibrioception (balance)

    Baseline (one measurement)

  • +1 more secondary outcomes

Study Arms (2)

Patient

Fatigue, cognition and quality of life measurements with different kind of tests and forms. EDSS and SFMC. Daily physical activity measurement 7days. Berg´s scale. Sit-Up 30 s and 6-minutes walking test. Length, weight and waist measurements.

Device: Physical Activity measurement:

Control

Healthy volunteers. Fatigue, cognition and quality of life measurements with different kind of tests and forms. SFMC. Daily physical activity measurement 7days. Berg´s scale. Sit-Up 30 s and 6-minutes walking test. Length, weight and waist measurements.

Device: Physical Activity measurement:

Interventions

7 days measurement with Active style Pro HJA-350IT device

ControlPatient

Eligibility Criteria

Age18 Years - 55 Years
Sexall
Healthy VolunteersYes
Age GroupsAdult (18-64)
Sampling MethodNon-Probability Sample
Study Population

Patient group: RRMS patients (18-55 years old) Control group: Healthy volunteers (18-55 years old)

You may qualify if:

  • RR-MS (relapsing-remitting MS-disease)
  • Age 18-55y
  • Expanded Disability Status Scale (EDSS) score less than equals to (\<=) 5.5
  • Not relapse in previous month

You may not qualify if:

  • PP-MS (primary progressive disease)
  • SPMS (secondary progressive disease)

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (4)

Joensuu

Joensuu, Finland

Location

Jyväskylä

Jyväskylä, Finland

Location

University of Eastern Finland

Kuopio, Finland

Location

Oulu

Oulu, Finland

Location

Related Publications (1)

  • Luostarinen M, Portaankorva AM, Urpilainen P, Takala S, Venojarvi M. Correlation of Cognition With Disability and Physical Performance in Patients With Relapsing-Remitting MS. J Cent Nerv Syst Dis. 2025 Jun 17;17:11795735251349716. doi: 10.1177/11795735251349716. eCollection 2025.

MeSH Terms

Conditions

Multiple Sclerosis, Relapsing-RemittingFatigueMotor Activity

Condition Hierarchy (Ancestors)

Multiple SclerosisDemyelinating Autoimmune Diseases, CNSAutoimmune Diseases of the Nervous SystemNervous System DiseasesDemyelinating DiseasesAutoimmune DiseasesImmune System DiseasesSigns and SymptomsPathological Conditions, Signs and SymptomsBehavior

Study Officials

  • Marko Luostarinen

    University of Eastern Finland

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
observational
Observational Model
CASE CONTROL
Time Perspective
PROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

April 4, 2019

First Posted

October 4, 2019

Study Start

May 16, 2018

Primary Completion

June 13, 2019

Study Completion

June 13, 2019

Last Updated

October 4, 2019

Record last verified: 2019-10

Locations